SUPRELORIN 4.7 MG IMPLANT

Country: Canada

Language: English

Source: Health Canada

Active ingredient:

DESLORELIN (DESLORELIN ACETATE)

Available from:

VIRBAC AH, INC.

Dosage:

4.7MG

Pharmaceutical form:

IMPLANT

Composition:

DESLORELIN (DESLORELIN ACETATE) 4.7MG

Administration route:

SUBCUTANEOUS

Units in package:

15G/50G

Prescription type:

Prescription Recommended

Therapeutic group:

DOGS

Product summary:

Active ingredient group (AIG) number: 0127552003

Authorization status:

APPROVED

Authorization date:

2022-04-21

Patient Information leaflet

SUPRELORIN 4.7 mg Implant
PI Virbac version 12 April 2022
1
PACKAGE INSERT
_ENGLISH_:
DIN XXXXXXXX
Pr
SUPRELORIN
®
4.7 mg Implant
(Deslorelin Implant) for Dogs
Veterinary Use Only
DESCRIPTION
SUPRELORIN 4.7 mg Implant is a white to pale yellow cylindrical
implant containing 4.7 mg deslorelin (as deslorelin
acetate).
DESLORELIN
i)
Deslorelin chemical structure
ii)
Amino acid sequence: pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-NHEt
iii)
Molecular formula: C
64
H
83
N
17
O
12
· xCH
3
COOH · yH
2
O
INDICATIONS
To temporarily suppress testosterone concentrations in healthy, entire
(intact), sexually mature male dogs to cause
infertility_._
DOSAGE AND ADMINISTRATION
One implant should be administered subcutaneously between the shoulder
blades of the dog.
Administer one implant only, irrespective of the size of the dog.
Testosterone suppression and infertility are not immediate.
Testosterone concentrations can be monitored to aid in
the determination of the period of infertility. Testosterone
concentrations less than 1.4 nmol/L (0.4 ng/mL) are
associated with infertility.
Do not use the product if the foil pouch is broken.
Disinfection of the implantation site should be undertaken prior to
implantation to prevent infection.
Select the implant site by locating the area of the back midway
between the shoulder blades.
Avoid injection of the implant into fat, as release of the active
substance might be impaired in areas of low
vascularization.
If the hair is long, a small area may be clipped, if required.
1. Remove the Luer Lock cap from the implanter.
2. Attach the actuator to the implanter using the Luer Lock
connection.
SUPRELORIN 4.7 mg Implant
PI Virbac version 12 April 2022
2
3. Lift the loose skin between the shoulder blades. Insert the entire
length of the needle subcutaneously.
4. Fully depress the actuator plunger and, at the same time, slowly
withdraw the needle.
5. Press the skin at the insertion site as the needle is withdrawn,
and maintain pressure for 30 seconds.
6. Examine the syringe and needle to ascertain